Drug intelligence / Profile preview

Fumaria officinalis

Development stage
Phase 3
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Fumaria officinalis L., commonly known as fumitory, is a plant traditionally valued in European and Asian herbal medicine. Its phytochemical composition is rich in isoquinoline alkaloids, such as protopine and stylopine, and various phenolic compounds including caffeoylmalic acid, quercetin dihexoside, rutin, and methylquercetin dihexoside. Scientific investigations highlight its potential for anti-inflammatory, hepatoprotective, and antioxidant activities. Specific compounds like stylopine have been identified as potential cyclooxygenase-2 (COX-2) inhibitors. The plant extract also demonstrates cytotoxic effects against leukemia and multiple myeloma cell lines and promotes diabetic wound healing by upregulating genes for vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-β), and fibroblast growth factor 2 (b-FGF). Formulations incorporating Fumaria officinalis extracts, such as nano-liposomal carriers and chitosan nanoparticles, are being explored for dermal applications and wound dressings.

02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)FGF2TGFB (GARP–latent transforming growth factor beta 1 complex)VEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on Fumaria officinalis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fumaria officinalis.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call